Virdings allé 18
Uppsala 754 50
Sweden
46 8 56 26 74 30
https://www.bio-works.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 48
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Jonathan Royce | Chief Exec. Officer | N/D | N/D | N/D |
Mr. Jan Berglöf | Co-Founder & Sr. Advisor | N/D | N/D | N/D |
Mr. Arne Hauge | Chief Financial Officer | N/D | N/D | N/D |
Mr. Karsten Fjärstedt | Chief Operating Officer | N/D | N/D | N/D |
Anna Lindqvist | Chief Marketing Officer | N/D | N/D | N/D |
Ms. Sara Ekvall | Director of People & Culture | N/D | N/D | N/D |
Ms. Helena Pahlm | Sr. Director of Global Quality | N/D | N/D | N/D |
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
L'ISS Governance QualityScore di Bio-Works Technologies AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.